Hovione Farmaciencia Sa, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HALOBETASOL PROPIONATE, with a corresponding US DMF Number 16953.
Remarkably, this DMF maintains an Active status since its submission on November 13, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 29, 2017, and payment made on November 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II